Artificial Intelligence: From Theory to Practical ApplicationsλArtificial Intelligence: From Theory to Practical Applications

Artificial intelligence is an interdisciplinary field combining mathematics, biology, psychology, and cybernetics to create systems capable of performing tasks requiring human intelligence. The technology is based on mathematical algorithms and data processing, not mystical processes.

ISO defines AI as the ability of a technical system to process external data, extract knowledge, and use it to achieve specific goals through flexible adaptation. The key difference between modern AI and traditional programming is the ability of systems to learn from experience without explicitly programming every step.

Machine learning as the foundation

Machine learning forms the basis of most modern AI applications. Systems automatically improve performance through data analysis, without prior description of all rules.

Supervised learning

The algorithm trains on labeled data — when correct answers are known in advance.

Unsupervised learning

The system identifies hidden patterns in unlabeled data independently.

Reinforcement learning

The system learns through interaction with the environment and receiving rewards for correct actions.

Neural networks, inspired by the biological structure of the brain, have become the dominant architecture in machine learning, especially in pattern recognition and natural language processing tasks.

Narrow AI versus general AI

It is critically important to separate actually working AI applications from marketing hype and inflated expectations.

Modern AI technologies cover a wide spectrum of applications — from virtual assistants to complex analytical systems processing terabytes of data. We distinguish narrow AI, specializing in specific tasks, and hypothetical artificial general intelligence, which remains a theoretical concept.

The accessibility of AI tools has increased significantly: numerous free online platforms allow users without deep technical knowledge to apply machine learning to solve practical tasks. However, this also creates a risk of overestimating the technology's capabilities — see myths about AI and how artificial intelligence works.

AI in medicine is a supportive tool, not a replacement for physicians. Systematic reviews and meta-analyses confirm: clinical judgment by specialists remains the central element of diagnosis.

The gold standard for evaluating medical AI systems is systematic reviews that combine results from multiple studies to obtain statistically significant conclusions, not isolated successful experiments.

Systematic Reviews as a Method for Validating AI Diagnostics

A systematic review is a structured literature analysis with explicit methods for selecting and critically evaluating studies. Meta-analysis complements it with statistical techniques that combine results from multiple works.

In the context of medical AI, this methodology separates real clinical effectiveness from marketing claims and isolated successes.

1. Identification of relevant studies in databases (PubMed, Cochrane)
2. Critical evaluation of the methodological quality of each study
3. Statistical combination of results to obtain pooled estimates
4. Analysis of data heterogeneity and sources of bias

Application in Oncology — Personalized Medicine and Cancer Subtypes

AI in oncology analyzes connections between patient characteristics (body mass index, menopausal status) and molecular subtypes of breast cancer. Many of these relationships remain unclear, highlighting the need for further research.

AI systems demonstrate potential in analyzing complex multifactorial data for treatment personalization. Clinical validation requires rigorous methodological standards: defining specific patient populations and comparing multiple treatment options based on evidence.

Ophthalmology and Anti-VEGF Therapy — Comparative Effectiveness

In ophthalmology, AI evaluates the effectiveness of anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) — a disease causing vision loss in elderly patients.

• Anti-VEGF drugs: blocking vascular endothelial growth factor requires comparing the effectiveness of different drugs and regimens
• AI analysis algorithms: processing retinal imaging data requires validation through randomized controlled trials
• Prognostic models: predicting response to therapy must rely on systematic reviews of comparative effectiveness

Systematic reviews in ophthalmology provide physicians with an evidence base for clinical decisions. AI algorithms help analyze imaging, but require validation through rigorous clinical trials.

Critical evaluation of AI technologies requires applying rigorous methodological standards borrowed from evidence-based medicine and the scientific method. Meta-analysis as a statistical tool allows combining results from multiple studies, compensating for small sample limitations and increasing the statistical power of conclusions.

Key quality criteria: presence of peer review, clear formulation of research questions, definition of specific populations, and comparative effectiveness analysis.

Checklist for Verifying AI Claims

1. Publication in peer-reviewed journals with explicit methodology description
2. Clear research questions and defined patient populations
3. Comparative effectiveness studies, not just theoretical models
4. References to primary research, not secondary interpretations
5. Separation between practical achievements and theoretical possibilities

Educational sources (Wikipedia, ISO, AWS, SAP) provide consistent definitions but have limitations: lack of peer review, possible commercial bias, focus on general audiences with less technical depth.

Critical red flags: absence of references to primary research, extraordinary claims without corresponding evidence, conflation of theoretical possibilities with practical achievements.

Interdisciplinary Approach — AI in Healthcare as a Bridge Between Technology and Medicine

Applying systematic reviews to evaluating AI claims combines the rigor of medical methodology with assessment of technological innovations. The evidence base for AI in healthcare must be built on the same principles as for pharmaceutical interventions: randomized controlled trials, systematic reviews, meta-analyses.

Peer Review

A quality filter that screens out methodological errors and unfounded conclusions. Its absence is the first sign of an unreliable source.

Primary Sources

Original research data. References to secondary interpretations hide methodological details and facilitate error propagation.

Comparative Effectiveness

Proof that an AI system works better than existing approaches, not just that it works in laboratory conditions.

Balancing demystification of AI technologies with maintaining realistic expectations requires focusing on practical applications that actually work today, rather than futuristic promises. English-speaking audiences need content that maintains scientific rigor while being accessible to a broad public.

Cloud Platforms and Accessible Business Tools

Cloud providers offer ready-made AI services without requiring deep machine learning expertise. AWS, Google Cloud Platform, Microsoft Azure, and other cloud providers offer APIs for natural language processing, computer vision, and predictive analytics.

SAP integrates AI capabilities into enterprise resource management systems, automating processes from procurement to logistics. The key advantage is scalability and pay-as-you-go pricing, which lowers the barrier to entry for small and medium-sized businesses.

Platform selection is determined not only by functionality, but also by compliance with industry security standards and regulatory requirements of specific jurisdictions.

Tool accessibility has increased: many platforms offer free service tiers and localized support. Cloud providers compete for market share by ensuring data storage compliance and local service delivery.

Real Implementation Cases Across Various Industries

In healthcare, AI systems function as auxiliary diagnostic tools. Algorithms demonstrate effectiveness in identifying parathyroid glands during surgical interventions and analyzing retinal images for age-related macular degeneration.

All medical AI applications are positioned as supplements to human expertise, not replacements—an approach consistent with evidence-based medicine principles.

In the corporate sector, AI is implemented to optimize supply chains, personalize customer experience, and automate routine processes.

1. Chatbots for initial customer support
2. Recommendation systems for e-commerce
3. Predictive analytics for inventory management

Critical analysis reveals a gap between marketing promises and actual capabilities: many "AI solutions" are basic machine learning algorithms wrapped in attractive packaging. Distinguishing working solutions from hype is aided by verification using the evaluation methodology described in the section on how artificial intelligence works.

Debunking Common Misconceptions About AI

The myth of AI's "magical" nature crumbles upon first contact with the mathematics: the technology is based on algorithms and data processing, not incomprehensible "digital magic." Modern systems are highly specialized and lack general intelligence — the notion that AI will "take over the world" ignores current limitations.

The cognitive trap of anthropomorphization leads to inflated expectations: systems that generate text or recognize images don't "understand" content in the human sense. They process statistical patterns. The term "artificial intelligence" itself creates an illusion of consciousness.

A critical approach requires distinguishing between narrow AI, which solves specific tasks, and hypothetical artificial general intelligence (AGI), which remains a theoretical concept without practical implementation.

Limitations of Current AI Systems and Areas of Uncertainty

The quality of AI outputs directly depends on the quality and completeness of training data. In medicine, this is critical: an algorithm trained on incomplete or biased data produces systematically flawed recommendations. Systematic reviews identify areas where connections remain unclear — for example, the relationship between body mass index, menopausal status, and breast cancer subtypes requires additional research.

The "black box" problem in deep neural networks makes it impossible to explain the logic behind specific decisions. This creates barriers for application in regulated industries where transparency is required.

Separating genuinely functional applications from hype and marketing exaggerations isn't just a useful skill — it's a necessity for making informed decisions about implementing AI systems.

International ISO Standards for Artificial Intelligence Systems

ISO has developed a series of standards defining terminology, quality requirements, and risk assessment methods for AI systems. ISO/IEC 22989 establishes a conceptual foundation and uniform understanding of key concepts on a global scale.

ISO/IEC 23053 focuses on a framework for assessing AI system trustworthiness, including metrics for accuracy, robustness, and safety.

Implementation of standards remains voluntary in most jurisdictions, creating unevenness in the quality and safety of AI systems on the market.

The United States participates in the standardization process through national technical committees, adapting international standards to the local context. Application of ISO standards allows organizations to demonstrate compliance with best practices, which is particularly important for exporting AI products and services.

Ethical Aspects and Security Concerns

Ethical principles for AI include transparency (explainability of decisions), fairness (absence of discriminatory biases), accountability (clarity of responsibility for errors), and privacy (protection of personal data).

The problem of algorithmic bias arises when training data reflects historical discriminatory patterns: hiring systems may discriminate by gender, credit scoring algorithms by ethnicity.

AI system security includes protection against adversarial attacks, where malicious actors manipulate input data to obtain erroneous outputs. Long-term risks associated with autonomous weapons systems and potential labor market displacement require proactive regulation and international cooperation.

Balancing innovation incentives with protection of public interests remains the central challenge for regulators across all jurisdictions.